Skip to main content

Table 1 Demographic and clinical data of the study groups at enrollment

From: Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study

 

Intervention (N = 195)

Control (N = 68)

p-valuea

Age (years)

  < 50

47 (24.1%)

15 (22.1%)

 

 50-59

68 (34.9%)

22 (32.4%)

 

  ≥ 60

80 (41.0%)

31 (45.6%)

 

 Range

20-85

33-83

 

 Mean ± SDb

56.9 ± 12.0

57.7 ± 11.6

0.649

Sex

 Male (92)

67 (34.4%)

25 (36.8%)

0.720

 Female (171)

128 (65.6%)

43 (63.2%)

 

Comorbidities

 Numberb

2.3 ± 0.8

3.0 ± 1.0

<0.001

 Hypertension

59 (30.3%)

48 (70.6%)

<0.001

 Dyslipidemia

90 (46.2%)

65 (95.6%)

<0.001

 Cardiac disease

33 (16.9%)

9 (13.2%)

0.475

 Cerebrovascular disease

4 (2.1%)

0 (0.0%)

0.234

 Renal disease

29 (14.9%)

9 (13.2%)

0.741

 Hypothyroidism

28 (14.4%)

8 (11.8%)

0.592

 Others

4 (2.1%)

0 (0.0%)

0.234

Diabetes Durationb (years)

1.21 ± 0.3

1.16 ± 0.3

0.238

Body weight (Kg)b

82.9 ± 17.6

74.8 ± 14.3

<0.001

Glycemic control‡

 HbA1c (%)

11.2 ± 1.4

10.1 ± 1.6

<0.001

 HbA1c (mmol/mol)

99 ± (84–114)

87 ± (69–104)

 

 Fasting blood glucose (mmol/l)

12.3 ± 4.6

12.2 ± 4.3

0.865

Blood lipids (mmol/l)‡

 Total cholesterol

4.7 ± 1.3

5.0 ± 4.1

0.292

 Triglycerides

1.9 ± 1.9

1.6 ± 0.7

0.102

 HDL cholesterol

1.2 ± 0.3

1.1 ± 0.3

0.506

 LDL cholesterol

2.7 ± 1.0

2.7 ± 0.9

0.979

Blood pressure (mmHg)b

 Systolic

130.1 ± 13.3

129.1 ± 14.1

0.600

 Diastolic

73.2 ± 8.0

74.0 ± 8.2

0.481

  1. aUsing Chi-square unless mentioned otherwise
  2. bStudent t-test